Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multinational, Multicenter, Non-Comparative, Open Study With a 6 Months Follow-up Period to Demonstrate the Efficacy and Safety of Oral Levofloxacin 500 mg Once Daily in the Treatment of Chronic Bacterial Prostatitis (CBP)

NCT00277511 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00277511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00277511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multinational, Multicenter, Non-Comparative, Open Study With a 6 Months Follow-up Period to Demonstrate the Efficacy and Safety of Oral Levofloxacin 500 mg Once Daily in the Treatment of Chronic Bacterial Prostatitis (CBP)
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2003
Completion date
Not reported
Enrollment
120
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostatitis